William Blair & Company
CALA

William Blair & Company’s Calithera Biosciences, Inc CALA Stock Holding History

William Blair & Company’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-800
Closed -$91K – 1796
2019
Q4 		$91K Sell
800
-250
-24% -$18.8K ﹤0.01% 1420
2019
Q3 		$65K Buy
1,050
+175
+20% +$14K ﹤0.01% 1428
2019
Q2 		$111K Buy
+875
New +$99.3K ﹤0.01% 1410

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

William Blair & Company's CALA Position: Q1 2020 in Review

William Blair & Company sold out of Calithera Biosciences, Inc (CALA) in Q1 2020, closing a stake of 800 shares — an estimated $91K sold.

William Blair & Company first reported a position in CALA in Q2 2019 and held it in 3 quarters. The position peaked at $111K in Q2 2019. 80 funds tracked by Wall St. Rank hold CALA as of Q1 2020.

  • William Blair & Company reported no remaining Calithera Biosciences, Inc position as of Q1 2020 after selling out during the quarter.
  • William Blair & Company sold 800 Calithera Biosciences, Inc shares in Q1 2020, an estimated $91K.
  • William Blair & Company first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 3 quarters.
  • William Blair & Company's Calithera Biosciences, Inc position peaked at $111K in Q2 2019.
  • 80 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2020.

Based on William Blair & Company's 13F filing for Q1 2020, filed 11 May 2020.